You searched for "correction"

3128 results found

Twenty-four hour IOP patterns in patients with thyroid eye disease (OO/GL)

Elevated IOP in patients with thyroid eye disease (TED) can be caused by restriction and compression of the globe by enlarged extraocular muscles, elevated episcleral venous pressure and increased mucopolysaccharide deposition in the trabecular meshwork. Although previous studies have investigated...

Limitations batted away at Glasgow blind cricket event

A unique event is being run in Glasgow this weekend for blind and sighted people to have a go at visually impaired cricket.

RCOphth 2024 Report

A comprehensive tapestry of all our RCOphth Annual Congress content captured between 20–23 May 2024.

Effect of alcohol dependency on visual function

The purpose of this study was to evaluate visual function, attention and psychological profiles in consumer and abstainer alcohol dependency syndrome (ADS) patients in a Portuguese population. The study was a quantitative, descriptive, cross-sectional and correlational study over a one-year...

Understanding optical lab processes at 100% Optical

Boosting understanding amongst the entire practice team about what happens in the optical lens manufacturing process was a keynote lecture which drew a packed audience to the OSA stand at 100% Optical.

An interview with Rachel Morris: Clinician wellbeing and difficult conversations

In the last wellbeing supplement, I interviewed Robert Self, Vice President of the Association of Anaesthetists, and we discussed the resources that doctors can access when experiencing problems with their wellbeing. One of those that he recommended was the podcast...

My Top Five: Promising gene therapies for ocular conditions

Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

My Top Five: Promising gene therapies for ocular conditions

Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

A case of Miller Fisher Syndrome and bilateral asymmetric globe retraction

Miller Fisher syndrome (MFS) is a rare, acquired nerve disease that is considered to be a variant of Guillain-Barré syndrome. It was first recognised by James Collier in 1932 as a clinical triad of ataxia, areflexia and ophthalmoplegia. Later, it...

Pituitary tumours: why are they so often missed?

Part 3: Clinical features, assessment and management (see also Part 2, and Part 1) As previously mentioned in this treatise [1] pituitary tumours are common, occur in all age groups and can present with anything from minimal visual symptoms to...

Practical phacodynamics – making the most of your phacoemulsification machine

Understanding phacodynamics is appreciating the subtleties in the dynamic changes of the fluidics and the ultrasonic power delivered. Kristina Southcott explains. Increase my vacuum! Increase my bottle height! Increase my phaco power! I frequently observe the above commands being directed...

Effect of single intravitreal injection of bevacizumab on contrast sensitivity in patients with central retinal vein occlusion

Central retinal vein occlusion is the second most common retinal vascular disorder after diabetic retinopathy. There are many studies reporting the efficacy of intravitreal anti-VEGF injections for macular oedema secondary to retinal vein occlusions. This paper looks at the contrast...